CF
MRNA icon

Corebridge Financial’s Moderna MRNA Stock Holding History

Corebridge Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-83,776
Closed -$2.38M – 1710
2025
Q1 		$2.38M Sell
83,776
-2,930
-3% -$104K 0.01% 921
2024
Q4 		$3.61M Sell
86,706
-28,775
-25% -$1.38M 0.02% 817
2024
Q3 		$7.72M Sell
115,481
-1,539
-1% -$141K 0.04% 538
2024
Q2 		$13.9M Buy
+117,020
New +$14.8M 0.08% 227

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Corebridge Financial's MRNA Position: Q2 2025 in Review

Corebridge Financial sold out of Moderna (MRNA) in Q2 2025, closing a stake of 83,776 shares — an estimated $2.38M sold.

Corebridge Financial first reported a position in MRNA in Q2 2024 and held it in 4 quarters. The position peaked at $13.9M in Q2 2024. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Corebridge Financial reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 83,776 Moderna shares in Q2 2025, an estimated $2.38M.
  • Corebridge Financial first reported a position in Moderna in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Moderna position peaked at $13.9M in Q2 2024.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.